| Intravenous immunoglobulin: an update on the clinical use and mechanisms of action VS Negi, S Elluru, S Siberil, S Graff-Dubois, LUC Mouthon, ... Journal of clinical immunology 27, 233-245, 2007 | 337 | 2007 |
| Molecular aspects of human FcγR interactions with IgG: functional and therapeutic consequences S Sibéril, CA Dutertre, C Boix, E Bonnin, R Ménez, E Stura, S Jorieux, ... Immunology letters 106 (2), 111-118, 2006 | 136 | 2006 |
| FcγR: the key to optimize therapeutic antibodies? S Siberil, CA Dutertre, WH Fridman, JL Teillaud Critical reviews in oncology/hematology 62 (1), 26-33, 2007 | 128 | 2007 |
| Selection of a human anti-RhD monoclonal antibody for therapeutic use: Impact of IgG glycosylation on activating and inhibitory FcγR functions S Sibéril, C de Romeuf, N Bihoreau, N Fernandez, JL Meterreau, ... Clinical Immunology 118 (2-3), 170-179, 2006 | 116 | 2006 |
| Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP S Gérart, S Sibéril, E Martin, C Lenoir, C Aguilar, C Picard, O Lantz, ... Blood, The Journal of the American Society of Hematology 121 (4), 614-623, 2013 | 112 | 2013 |
| Isolation and characterization of anti-FcγRIII (CD16) llama single-domain antibodies that activate natural killer cells G Behar, S Sibéril, A Groulet, P Chames, M Pugniere, C Boix, ... Protein Engineering, Design & Selection 21 (1), 1-10, 2008 | 104 | 2008 |
| Rescuing CD4+ CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy J Bayry, S Sibéril, F Triebel, DF Tough, SV Kaveri Drug discovery today 12 (13-14), 548-552, 2007 | 90 | 2007 |
| Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the … J Bayry, EM Fournier, MS Maddur, J Vani, B Wootla, S Sibéril, JD Dimitrov, ... Journal of autoimmunity 36 (1), 9-15, 2011 | 88 | 2011 |
| Fcγ receptor-like activity of hepatitis C virus core protein P Maillard, JP Lavergne, S Sibéril, G Faure, F Roohvand, S Petres, ... Journal of Biological Chemistry 279 (4), 2430-2437, 2004 | 74 | 2004 |
| Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective S Siberil, S Elluru, S GRAFF‐DUBOIS, VIRS NEGI, S Delignat, L Mouthon, ... Annals of the New York Academy of Sciences 1110 (1), 497-506, 2007 | 54 | 2007 |
| Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG S Rigaud, E Lopez-Granados, S Sibéril, G Gloire, N Lambert, C Lenoir, ... Blood, The Journal of the American Society of Hematology 118 (2), 252-261, 2011 | 44 | 2011 |
| Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies S Sibéril, SR Elluru, VS Negi, A Ephrem, N Misra, S Delignat, J Bayary, ... Transfusion and Apheresis Science 37 (1), 103-107, 2007 | 44 | 2007 |
| Activation of human peripheral IgM+ B cells is transiently inhibited by BCR-independent aggregation of FcγRIIB EM Fournier, S Sibéril, A Costes, A Varin, WH Fridman, JL Teillaud, ... The Journal of Immunology 181 (8), 5350-5359, 2008 | 27 | 2008 |
| Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors D Bourel, C De Romeuf, S Siberil, WH Fridman, JL Teillaud, N Bihoreau, ... US Patent 7,790,399, 2010 | 26 | 2010 |
| Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination O Bonduelle, N Yahia, S Siberil, N Benhabiles, F Carrat, A Krivine, ... The Journal of Immunology 191 (2), 623-631, 2013 | 25 | 2013 |
| Keeping the memory of influenza viruses B Combadière, S Sibéril, D Duffy Pathologie Biologie 58 (2), e79-e86, 2010 | 25 | 2010 |
| Impact of depleting therapeutic monoclonal antibodies on the host adaptive immunity: a Bonus or a Malus? C Deligne, B Milcent, N Josseaume, JL Teillaud, S Sibéril Frontiers in Immunology 8, 281677, 2017 | 18 | 2017 |
| Effect of zinc on human IgG1 and its FcγR interactions S Sibéril, R Ménez, S Jorieux, C de Romeuf, D Bourel, WH Fridman, ... Immunology Letters 143 (1), 60-69, 2012 | 18 | 2012 |
| Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes S Siberil, CA Dutertre, C Boix, JL Teillaud Transfusion Clinique et Biologique: Journal de la Societe Francaise de …, 2005 | 18 | 2005 |
| Comparative study of the anti-inflammatory effect of two intravenous immunoglobulin preparations manufactured by different processes SR Elluru, JPD Van Huyen, J Bayry, S Delignat, F Prost, A Ephrem, ... Immunology letters 107 (1), 58-62, 2006 | 17 | 2006 |
